Penny Stock to Watch Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) is now covered by analysts at Canaccord Genuity. Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. With the recent surge VVUS had after FDA approval, betting on penny stock biotechs with new drugs pending FDA approval may have just become the best ...
7
MAR
MAR
0
Share
